.infobox .infobox-gene
| Gene Symbol | RNF8 |
|---|---|
| Gene Name | Ring Finger Protein 8 |
| Chromosome | 6p21.1 |
| NCBI Gene ID | 9027 |
| OMIM ID | 611685 |
| Ensembl ID | ENSG00000137243 |
| UniProt ID | Q9UPW4 |
| Associated Diseases | DNA Repair Disorders, Cancer Predisposition, Neurodevelopmental Disorders, Neurodegeneration |
| --- | --- |
| Categories | DNA Repair, Genome Stability, Ubiquitin-Proteasome System |
RNF8 (Ring Finger Protein 8) is an E3 ubiquitin ligase that plays a critical role in the cellular response to DNA double-strand breaks. Together with its partner RNF168, RNF8 initiates the ubiquitination cascade that recruits repair proteins to damaged chromatin. This function is particularly important in post-mitotic neurons, which cannot rely on DNA replication to eliminate damaged cells.
RNF8 is a RING finger E3 ubiquitin ligase that specifically targets histone H2A and H2AX at DNA double-strand break (DSB) sites. The enzyme's activity is essential for efficient DNA repair, genome stability, and cell survival. Dysregulation of RNF8-mediated DNA repair pathways has been implicated in cancer, neurodegeneration, and aging.
RNF8 is the initial E3 ligase in the DNA damage response (DDR) cascade:
Recognition: Following DSB formation, ATM kinase phosphorylates histone H2AX (generating γ-H2AX), which serves as a platform for recruiting additional repair proteins [1].
Ubiquitination Cascade: RNF8, in complex with its E2 conjugating enzyme (typically UBC13), catalyzes K63-linked polyubiquitin chain formation on histone H2A and H2AX [2].
RNF168 Amplification: The ubiquitin marks created by RNF8 recruit RNF168, which extends the ubiquitin chains and creates binding sites for additional repair factors [3].
Repair Protein Recruitment: Ubiquitinated histones recruit proteins including 53BP1, BRCA1, and RAP80 to damage sites.
RNF8-mediated ubiquitination promotes chromatin remodeling at damage sites:
Beyond DNA repair, RNF8 influences transcription:
RNF8 contains several functional domains:
The enzyme functions as a homodimer, with dimerization essential for catalytic activity.
Interestingly, RNF8 has opposing roles in cancer and neurodegeneration:
This duality makes RNF8 an interesting therapeutic target, requiring careful modulation.
Targeting RNF8-mediated DNA repair pathways offers therapeutic opportunities:
The study of Rnf8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.